Johnson & Johnson Talc Asbestos Concealment: What the Evidence Shows and What It Means for Your Family
If you are reading this, someone you love has been diagnosed with mesothelioma or ovarian cancer, and you have spent a lifetime — or watched someone spend a lifetime — using talc powder products that were marketed as safe enough for a baby. The diagnosis may have come decades after the exposure. You may be in treatment right now, or you may be grieving someone who is gone. Either way, you are here because something does not sit right, and you are looking for someone to tell you the truth about what the company knew and when.
We are going to give you that truth. Not our opinion — the testimony and the documents that have come out of courtrooms where Johnson & Johnson has been forced to answer for what its own scientists found inside its talc and what its executives did with that information. What follows is a full explanation of the evidence, the law, the medicine, the corporate shell game J&J has played to try to wall these claims off, and the deadlines that govern whether you can still bring a claim. We are Attorney911 — The Manginello Law Firm, PLLC, and we handle toxic tort and product liability cases for people across the country whose lives were changed by products they were told were safe. We do not charge a fee unless we win your case, and the consultation is free. Call us at 1-888-ATTY-911, any hour, any day. We have live staff — not an answering service — and we speak Spanish.
Did Johnson & Johnson Withhold Asbestos Test Results From the FDA?
The U.S. Food and Drug Administration regulates cosmetic products containing talc under the Federal Food, Drug, and Cosmetic Act. Cosmetics do not require premarket FDA approval — meaning the government does not test talc powder before it reaches a store shelf. The system depends on companies being honest with the regulator about what they know. The FDA asked Johnson & Johnson to turn over all relevant testing documents about the presence of asbestos in its talc products. J&J represented that it had done so.
Then John Hopkins sat for his deposition. And when he was asked whether he had ever seen evidence that his asbestos findings — the report with the photographs, the unmistakable identification of chrysotile fibers — had been provided to the FDA, his answer was effectively no. He had never seen evidence that his research reached the agency.
This is the center of the case. The company’s own scientist found asbestos, documented it, warned about it internally — and the finding apparently never made it to the federal regulator that was specifically asking for it. The gap between what J&J knew internally and what it disclosed to the FDA is the spine of the fraudulent concealment allegations that run through both the ovarian cancer litigation and the separate mesothelioma litigation against the company.
The FDA’s own subsequent independent testing later detected asbestos in cosmetic talc products. Johnson & Johnson eventually announced it was discontinuing talc-based Baby Powder in North America. The question every family affected by these products should be asking is simple: if the company’s own toxicologist found asbestos years ago, why did it take so long for the product to come off the shelf — and why did the finding not reach the FDA when the agency asked?
The Defendant: Johnson & Johnson’s Corporate Structure and the Bankruptcy Shell Game
Johnson & Johnson is not a single entity you can simply sue and collect from. It is a corporate family — and over the past several years, it has deliberately restructured that family to try to wall off the talc liability from the assets that would pay for it.
The parent company is Johnson & Johnson, headquartered in New Brunswick, New Jersey. The historical seller of the talc products was Johnson & Johnson Consumer Inc. (JJCI). In 2023, J&J spun off its consumer health business into a separate publicly traded company called Kenvue Inc. — which now owns brands like Band-Aid, Tylenol, and Listerine, while J&J retained indemnity obligations for talc liability. Whether Kenvue or J&J ultimately bears the talc liability is itself a live legal question, and the corporate restructuring was designed in part to complicate the answer.
Then there is the bankruptcy strategy — what critics call the “Texas Two-Step.” J&J used a Texas divisional merger statute to split its consumer health business into two entities: one that held the talc liability and one that held the assets. The liability entity — first called LTL Management LLC, then renamed Red River Talc LLC — filed for Chapter 11 bankruptcy to try to channel all talc claims into a bankruptcy trust, capping the company’s exposure and forcing claimants to accept whatever the trust would pay.
Three times J&J tried this. Three times it failed.
The first LTL bankruptcy was dismissed by the Third Circuit Court of Appeals in April 2023, which found the filing was not made in good faith because J&J had not come close to actual financial distress. The second attempt met a similar fate. The third attempt — filed by Red River Talc LLC — was dismissed on March 31, 2025, by U.S. Bankruptcy Judge Christopher Lopez of the Southern District of Texas, who found vote-solicitation irregularities and impermissible nonconsensual third-party releases. As of the most recent public record, J&J has pivoted back to defending cases in the tort system rather than through another bankruptcy filing.
What this means for you is that the bankruptcy door — the one J&J was trying to force every claimant through — is currently closed. Claims are proceeding in courts. But the company has demonstrated it will try unconventional legal strategies to limit its exposure, and anyone considering a claim should be aware that the procedural landscape can shift. This is one of many reasons to talk to a lawyer now rather than waiting to see what happens.
There are also potential claims against raw talc suppliers — including the Italian talc sources referenced in the internal documents about the study on Italian talc miners. If J&J sourced contaminated talc from third-party mines, those suppliers may face parallel product liability for introducing asbestos-contaminated raw material into the stream of commerce. Identifying every entity in the supply chain is part of building a complete case.
The Evidence Clock: What Records Exist and How Fast They Disappear
In a toxic tort case with a decades-long latency period, evidence preservation is not a formality — it is the case. The disease appears twenty, thirty, or forty years after the exposure. The documents that prove what the company knew, and when, are the bridge between that long-ago exposure and today’s diagnosis. And some of those documents are on clocks.
J&J internal testing records — including all Hopkins reports, laboratory data, and the asbestos fiber identification photographs — are held by Johnson & Johnson. These records are subject to litigation holds in active cases, but the corporate restructuring (the Kenvue spinoff, the LTL/Red River bankruptcies) creates genuine spoliation risk. Employee turnover, document retention cycles, and the physical movement of records between entities mean that documents can be “lost” in ways that are difficult to prove but devastating to a case. The preservation letter that goes out the day you call a lawyer is the countermeasure.
Executive communications, meeting minutes, and strategic memoranda — the documents discussing “compromising” research and “controlling” studies — are the most damaging documents in the entire case and the most likely to face spoliation pressure. Prior talc litigation has already surfaced many of these documents, but the full universe may not have been produced. Aggressive, targeted discovery is essential.
FDA correspondence and submission records — the complete record of what J&J told the FDA and when — are retained per federal schedule, but corporate copies of submissions and internal drafts are subject to litigation holds. The gap between what J&J knew internally and what it disclosed to the FDA is the fraudulent concealment centerpiece, and the document-by-document comparison is how that gap is proven.
Talc sourcing, supply chain, and quality control records — including documentation of Italian talc mine sources — prove knowledge of contamination at the raw material level and identify potential additional defendants among suppliers. These records may be scattered across multiple vendor relationships and jurisdictions.
Your own pathology records, tissue block specimens, and exposure history — this is the evidence that proves specific causation. Tissue specimens must be preserved for forensic asbestos analysis — a pathologist can identify asbestos fibers in lung tissue or ovarian tissue, directly linking the disease to the exposure. Treating physicians retire, records are purged per hospital retention schedules, and product purchase history fades with time. If you or a loved one has been diagnosed, the single most important evidence — the tissue blocks from the biopsy or surgery — needs to be identified and preserved immediately. Hospitals retain pathology blocks for years, but the clock is running, and once they are destroyed, the physical proof of asbestos in the body is gone.
Current Status of J&J Talc Litigation and Bankruptcy Proceedings
As of the most recent public record, the federal multidistrict litigation consolidating thousands of talc-related ovarian cancer claims — MDL-2738, In re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation — is pending in the U.S. District Court for the District of New Jersey before Judge Michael A. Shipp. The MDL docket has carried tens of thousands of actions. Individual cases also proceed in state courts across the country, with significant verdicts historically emerging from Missouri state courts in St. Louis and from California venues.
The trial described in the testimony above — the one where Hopkins was deposed and the internal documents were shown to the jury — is one of numerous individual proceedings across multiple state and federal courts. It is not the only courtroom where this evidence has been or will be presented. The Hopkins deposition and related documents create a narrative of systematic concealment that can anchor every phase of every trial where they are admitted.
On the bankruptcy front, J&J’s third attempt — the Red River Talc LLC Chapter 11 filing — was dismissed on March 31, 2025. The court found vote-solicitation irregularities and impermissible nonconsensual third-party releases. J&J has indicated a pivot back to defending cases in the tort system. However, the company’s bankruptcy strategy has been evolving, and anyone with a potential claim should monitor the procedural landscape and act promptly rather than assuming the current state will persist indefinitely.
A prior consolidated talc verdict provides context for what juries have done when presented with this evidence. In the Missouri case of Ingham v. Johnson & Johnson, a jury returned a verdict of $4.69 billion in July 2018. The Missouri Court of Appeals reduced that to approximately $2.12 billion in June 2020. The U.S. Supreme Court denied certiorari on June 1, 2021, meaning the reduced award stood. That is a real number, affirmed through the highest court in the country — not a press release, not a promise, but a judgment that survived appeal. Past results depend on the facts of each case and do not guarantee future outcomes, but the Ingham case demonstrates what a jury can conclude when presented with the evidence of what J&J knew and what it concealed.
The First 72 Hours: What to Do Now
If you or someone you love has been diagnosed with mesothelioma, ovarian cancer, or another asbestos-related disease after long-term use of talc products, here is what should happen — and what should not happen — in the days ahead.
Do get the pathology records secured. The tissue blocks from the biopsy or surgery are the physical evidence that can prove asbestos fibers were in the body. Contact the pathology department at the hospital where the diagnosis was made and ask how to ensure those blocks are preserved. A lawyer’s preservation letter to the hospital can formalize this, but you can start the conversation yourself today.
Do write down the product use history. What products were used, how often, for how many years, and by whom? Was it J&J Baby Powder specifically, or another J&J talc product? Was it used daily after showering, after changing diapers, as a deodorant substitute? The more specific the timeline, the stronger the causation case. Memories fade and product packaging is discarded — write it down now while the details are still available.
Do gather any other exposure history. If there were occupational asbestos exposures — a spouse who worked in construction, a factory, a refinery, a shipyard — those should be documented too. The defense will try to attribute the cancer to those sources, and the counter requires a complete picture of every exposure.
Do not sign anything from any insurance company, claims administrator, or representative of Johnson & Johnson. Do not accept a quick settlement offer. Do not give a recorded statement. Do not assume that a letter offering you “compensation” is anything other than an attempt to close your claim for a fraction of its value.
Do not post about the diagnosis or the product use on social media. Defense investigators monitor public posts. Anything you write can be taken out of context and used to undermine your claim.
Do call a lawyer. The preservation letter that freezes J&J’s internal documents, the FDA submission records, and the hospital pathology blocks goes out the day you retain counsel. Every day before that letter is a day the evidence is unprotected. We send preservation letters as part of our evidence protocol. Call us at 1-888-ATTY-911 — the consultation is free, and we do not get paid unless we win your case.
Why This Firm
We are Attorney911 — The Manginello Law Firm, PLLC. We have been handling catastrophic injury and wrongful death cases since 2001. Our managing partner, Ralph P. Manginello, has been licensed to practice law in Texas since November 1998 — more than 27 years — and is admitted to federal court in the Southern District of Texas. He was a journalist before he was a lawyer, which means he knows how to find the story the documents tell and how to put that story in front of a jury in language they cannot forget. He is a member of the Texas Trial Lawyers Association and the Houston Bar Association, and he serves as lead counsel in the active $10 million hazing lawsuit against Pi Kappa Phi and the University of Houston.
Lupe Peña is our associate attorney, licensed in Texas since 2012 and admitted to the same federal court. Before he joined this firm, Lupe spent years inside a national insurance-defense firm — the rooms where adjusters and their software decided how to deny, delay, and devalue people exactly like you. He knows how claims are valued from the inside, how IME doctors are selected, how surveillance is used, and how delay tactics work. Now he uses that knowledge for injured clients. Lupe is fluent in Spanish and conducts full consultations in Spanish without an interpreter. Hablamos Español.
We handle cases on a contingency fee basis: 33.33% before trial, 40% if the case goes to trial. We do not get paid unless we win your case. The consultation is free. We have 24/7 live staff — not an answering service — and we can be reached at 1-888-ATTY-911 or through our contact page.
We also have specific experience with mesothelioma and toxic exposure cases — including asbestos and benzene exposure from refinery and industrial work. The medicine, the latency, the dose reconstruction, the corporate accountability fight — these do not change because the mechanism of exposure is cosmetic talc instead of occupational asbestos. The same science that proves asbestos causes mesothelioma in a refinery worker proves it in a woman who used Baby Powder every day for thirty years. What changes is the defendant and the product. The fight is the same.
If you are facing a mesothelioma or ovarian cancer diagnosis and you used talc products for years, call us. Not because we promise a result — no honest lawyer can do that. Because the evidence of what Johnson & Johnson knew is growing stronger with every trial, because the deadlines in your state are real, and because the preservation of your evidence — the tissue blocks, the product history, the documents that prove what the company concealed — cannot wait. The day you call is the day the clock starts working for you instead of against you.
1-888-ATTY-911. Free consultation. No fee unless we win. Hablamos Español.
This page is legal information, not legal advice. Past results depend on the facts of each case and do not guarantee future outcomes. Contacting the firm is free and confidential. The firm works with local counsel or pro hac vice admission where required in jurisdictions outside Texas.